ARCHIVES

In Brief: Frozen Panels Available to Evaluate diagnostic Assays; Panel to Meet at Johns Hopkins April 22

This article is from The Cancer Letter archive.

Vol. 11 No. 11 | March 15, 1985

Download PDF Visit The Full Archive

Related Articles

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Annual Report Finds Cancer Incidence And Death Rates Fell For First Time.

December 5, 2008

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

NCI Funds; Ad Hoc Group Approves NCCTG Renewal

September 18, 1981

ASCO Urges Doubling Cooperative Group Program Budget

April 16, 2010

PDX Shows 27% Response In T-Cell Lymphoma In Study

December 26, 2008